Introduction
New human leukocyte antigen (HLA) alleles continue to be revealed and the recognition of HLA low incidence alleles has enriched our understanding of the complexity of the HLA system. The major histocompatibility complex (MHC) in humans consists of several loci of genes that are located on the short arm of chromosome 6 at 6p21.3. These loci are classified into MHC Class I, Class II, and Class III regions. The genes encoding the HLA alleles are located in the MHC Class I and Class II regions. HLA genes are characterized by their extreme allelic polymorphism as well as their variations and diversity in different ethnic groups and racial populations. HLA molecules have been definitely defined as transplant antigens and have a strong relevance in tissue transplantation. The molecular similarity between donors and recipients is being considered a predictive factor for graft survival and graft-versus-host disease. It is imperative to precisely characterize any unknown and low incidence alleles encountered during routine HLA typing procedures. To facilitate successful and comprehensive unrelated bone marrow hematopoietic stem cell donor searches for patients in need of hematopoietic stem cell transplantation, persistent efforts are needed to resolve unidentified, ambiguous or low incidence alleles to offer better HLA matching and donor selection.
The nucleotide sequence of HLA-A24:287 was first submitted to GenBank (accession number LK021330) and the name HLA-A24:287 (HWS1002300) was officially assigned by the World Health Organization HLA Nomenclature Committee in June 2014 [1] . However, there was no indication of its ethnicity and its associated HLA haplotype in the report. Here, we report the Taiwanese ethnicity of A24*287 and the deduced probable HLA haplotypes in association with A*24:287 based on the HLA-A, -B, and -DRB1 alleles commonly shared by the HLA typing of our donors and a donor (donor ID 360391) submitted to the IMGT database [1] . We further speculate that the deduced plausible HLA haplotypes associated with A*24:287 are restricted to Taiwanese.
Materials and methods
Peripheral whole blood samples from unrelated bone marrow hematopoietic stem cell donors with Taiwanese ethnicity were collected in acid citrate dextrose anticoagulant. Formal written consents were signed by the donors before blood collection. The acid citrate dextrose whole blood samples were stored at À80 C until use. Genomic DNA was extracted using QIAamp DNA Blood Mini Kits according to the manufacturer's instructions (Qiagen, Hilden, Germany). The DNA material was subjected to HLA genotyping for the HLA-A, HLA-B, and HLA-DRB1 loci using commercial polymerase chain reaction sequencing-based typing kits (Secore A/ B/DRB1 Locus Sequencing kits, Life Technologies, Brown Deer, WI, USA). High resolution allelic sequencing was performed as previously described [2e6]. The two sets of primer sequences used were: (1) B-CG: M13-BIN1-CGG (sense): TGTAAAACGACGGCCAG TCGGGGGCGCAGGACCCGG; P3'exon 5B (antisense): GCTCCGAT-GACCACAACTGCT; and (2) B-TA: M13-BIN1-TGA (sense): TGTAAAACGACGGCCAGTGGCGGGGGCGCAGGACCTGA; P3'exon 5B (antisense): GCTCCGATGACCACAACTGCT. The amplicons were sequenced using a BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems, Foster City, CA, USA) in both directions. The HLA allele-associated probable haplotypes postulated in this study were determined by looking at the commonly shared HLA typing of the donors carrying A*24:287. Where applicable, haplotype deduction based on HLA allelic homozygosity is as described previously [7, 8] 
Results
We confirmed that the DNA sequence of A*24:287 is identical to A*24:02:01:01 in exon 2 and exon 3, except for residue 617 where C is changed to G (codon 182, ACG->AGG) ( 
Discussion
We confirmed the DNA sequence and amino acid sequence of the HLA allele A*24:287 in this study. A*24:287 was initially detected in an individual from Taiwan (with HLA typing of A*02, A*24:287, B*40, B*67, DRB1*15, and DRB1*16) [1] . We deduced the two probable A*24:287-associated HLA haplotypes to be A*24:287-B*40-DRB1*15 and A*24:287-B58-DRB1*0301, based on the commonly shared HLA typing of three donors carrying A*24:287 (1 of them with HLA-B and -DRB1 homozygosity; A*24:287, A*33, B*58, and DRB1*03:01) listed in our registry and the donor information submitted to the IMGT (D360391) ( Table 1 ). We further speculate that individuals bearing the A*24:287 allele are probably Taiwanese, since the donors carrying A*24:287 in our registry and the donor (D360391) with A*24:287 reported to the IMGT/HLA database [1] are all Taiwanese.
It is worth mentioning that the most direct and classic method to determine HLA haplotype is through family study if test materials from a number of key family members are available. Alternatively, a population study may be employed if a significant number of unrelated donors is available [2] . However, the haplotypes deduced via population investigation are considered likely or most probable. In this study, because of the lack of availability of necessary test materials from the families of the donors with A*24:287, we opted to determine the haplotype by looking at the HLA alleles carried in common by unrelated donors bearing the same alleles of interest. Also, if determination of plausible HLA haplotypes is for rare or low frequency HLA alleles, the alleles shared in common by unrelated individuals may be employed to deduce associated probable haplotypes [3e6,9e12] .
The frequency of A*24:287 in Taiwanese is about one in 40,000 according to our HLA typing practice. To date, the Allele Frequency Net Database (http://www.allelefrequencies.net/hla6006a.asp? hla_locus_type¼Classical#) has yet to show the existence of the allele in the world population. Therefore, we think the probable A*24:287-associated HLA haplotypes in Taiwanese that we deduced in this study are highly accountable.
The significance of determining the ethnicity of individuals with A*24:287 and its HLA linked haplotypes is that the information may be employed in anthropological investigation of races in addition to allowing search coordinators in unrelated bone marrow donor registries to allocate appropriate unrelated bone marrow hematopoietic stem cell donors for their patients.
The numbers of known HLA alleles are increasing exponentially with the recent development of DNA-based molecular typing technology. Understanding HLA diversity in ethnic groups is important. Facilitating an appropriate HLA-matched unrelated bone marrow stem cell donor for successful stem cell transplantations relies on the accuracy of HLA typing and the determination to resolve unknown, ambiguous, and low incidence genes in the HLA system. Additionally, determination of haplotypes is essential for matching in unrelated stem cell transplantation between donor and recipient, since matching at the haplotype level has a better likelihood of matching at other loci within the HLA region than that for donors merely matched at the individual allelic level.
